Clinical trial
Cromoglicte Adjunctive Therapy for Outpatients With Schizophrenia
NCT03794076 is registered in ClinicalTrials.gov with Vishwajit Nimgaonkar, MD PhD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cromoglicte Adjunctive Therapy for Outpatients With Schizophrenia
- Lead sponsor
- Vishwajit Nimgaonkar, MD PhD
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- April 1, 2019
- Completion date
- June 30, 2028
- Enrollment
- 160 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
schizo affective disorder, schizophrenia